1. Search Result

Search Result

Results for "2186700-33-2" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-111620


    Acyltransferase Metabolic Disease Inflammation/Immunology
    Ervogastat (PF-06865571) is a potent and well-tolerated diacylglycerol acyltransferase 2 inhibitor (DGAT2i). Ervogastat alone reduces steatosis and hepatic triglyceride levels in non-alcoholic steatohepatitis (NASH). Ervogastat combination with Clesacostat (an acetyl CoA-carboxylase inhibitor (ACCi)) can be used for the research of NASH with liver fibrosis therapy.